To provide epidemiological data on community-acquired pneumonia (CAP) and complicated CAP, a retrospective study was conducted on a partially vaccinated paediatric population. Data from children hospitalized for CAP in Tuscan hospitals between January I", 1999 and December 31"t, 2009 were analysed. A total of 5,450 children with CAP were hospitalized. Annual hospitalization rates for CAP did not change significantly over the study period ('i for trend= 0.652; p=0.419). The total annual
hospitalization rate for pneumococcal CAP varied according to age (28.04 per 100,000 children aged ::: 5 years, 10.06 per 100,000 children aged 6-12 years and 0.98 per 100,000 children aged~13years). Hospitalization rates for pneumococcal CAP increased from 12.84 (95% CI:7.35-18.34) in 2001 to 45.4 (95%CI:35.93-54.90) per 100,000 children aged::: 5 years in 2009 (p<O.OOOI). In addition, a significant increase of hospitalization rates for complicated CAP (from 6.07 in 1999 to 13.66 in 2009 per 100,000 children; P<O.OOOI) and pneumococcal complicated CAP (from 0.19 in 1999 to 3.41 in 2009 per 100,000 children) over the study period were highlighted. Our epidemiological data confirm the decision to introduce the PCV13 vaccine, to satisfy the need to prevent a wider group of pneumococcal serotypes.
Community acquired pneumonia (CAP) is a major cause of hospitalization in children living in Western countries, accounting for up to 18% of all pediatric hospital admissions (l, 2). Regional increases of CAP-associated complications, mostly empyema, were recently reported in British and United States children (3) (4) (5) .
Streptococcus pneumoniae is one of the main causes of CAP in children under 5 years of age, possibly associated with severe local complications including pleural effusion, empyema or lung abscess (l, 3) . Epidemiological data on invasive pneumococcal disease (IPD), including pneumonia and complicated pneumococcal CAP in children, have a wide variability in European countries, ranging from 3.1 in Spain to 110.2 in Portugal per 100,000 children (6, 7) . Accurate diagnosis of pneumococcal pneumonia is often difficult since the isolation or growth of the organism in specimens may lack. Therefore IPD hospitalization rates might be underestimated. In Italy available data on IPD incidence and hospitalization rates for CAP are limited and conflicting (8) (9) (10) . Moreover, Italian epidemiological data on IPD rates have changed dramatically since new molecular diagnosis methods have been widely employed in order to demonstrate Streptococcus pneumoniae infection in recent years (11, 12) .
Vaccination with heptavalent pneumococcal conjugate vaccine (PCV7) decreased IPD rates in children in randomised controlled trials (13, 14) . However, some authors recently suggested an increase in hospitalization rates for complicated CAP in childhood in western countries, despite PCV7 widespread use (16) (17) (18) .
In the present study, hospitalization rates for CAP and complicated CAP in Tuscan children, and their changes over an l l-year period were evaluated. Moreover, data on the aetiology of hospitalized CAP cases were analysed. Thus, our study provides unique epidemiological data which may be used to estimate the pediatric rates of CAP, pneumococcal CAP and all associated local complications in an area with a poorly vaccinated population.
MATERIALS AND METHODS
A retrospective cohort study was carried out, analysing children hospitalized for CAP in Tuscany in the period from January i-, 1999 to December 31st, 2009.
The Italian National Statistic Institute database provided the number of children living in Tuscany, by age group, during the study period. The total number of hospitalizations for pneumonia in all 31 Tuscan hospitals was initially collected, and a Regional database was the source of hospital discharge records. The widespread use of PCV7 in Tuscany started in 2007. Over the study period, among children aged 0-5 years, vaccination coverage ranged from 13.31% to 39.93% in 2007, from 15.66% to 45.93% in 2008 and from 19.78% to 59.75% in 2009 (Wyeth Lederle inc., personal communication). These figures are based on the number of vaccine doses sold in Tuscany (115,000 doses distributed in 2009). Thus, this was carried out on a poorly vaccinated population.
Case definition
Cases were identified by International Classification of Disease, Ninth Revision, Clinical Modification (lCD-9-CM), diagnostic codes for pneumonia as reported in several previous studies (3, 18) . A double-check using the records of the study children was undertaken to investigate possible duplication in reported cases due to eventual inpatient transfer between hospitals.
Inclusion criteria. Hospitalized children, aged < 18 years, living in Tuscany and discharged from a Tuscan hospital (pediatric as well as general wards) with the diagnosis of pneumonia were included in the study population. Cases were selected if pneumonia diagnosis code occurred in any diagnostic discharge positions, defined by the codes 481-486; 482.9; 487.0.
Exclusion criteria. As previously described (3), children with the following conditions were excluded because these comorbidities are characterized by risk factors not reflective of the general paediatric population: malignancies, congenital heart defects, cystic fibrosis, acquired or congenital immunological disorders, organ recipient and recipient of chemotherapy. Children with any diagnosis code oftrauma were also excluded assuming a nosocomial source of their pneumonia (3) . In addition, all neonatal «28 days of life) pneumonia cases and all pneumonia cases with related diagnosis code "in-hospital births" were excluded to avoid perinatally-acquired and neonatal nosocomial infections. Tuberculosis cases were excluded (3).
Complicated CAP
Complicated CAP were identified by the following codes: empyema 510,510.9,510.0; pleural effusion: 511.9; pleuritis: 511.0,511.1; lung abscess: 513.0 and 518.0 (3, 5) . Data on surgical interventions, such as thoracentesis, were recorded by using procedure diagnosis codes 3491, 3402, 3421 and 3409 (3, 16, 17) .
Statistical analysis
The study population was characterized on the basis ofage, gender, season of hospitalization, presence oflocal complications, hospital admission and mode of discharge. Age was expressed as median and interquartile range (IQR). Patients were divided by age into three groups «5 years; 6-12 years; > 13 years). Median length of stay and IQR for pneumonia were calculated. Rates of hospitalization for pneumonia and 95% confidence intervals (95% CI) were calculated as cases per 100,000 subjects aged I month to < 18 years living in Tuscany during the study period. Yearly changes among hospitalization rates for CAP and complicated CAP were analysed by X 2 test. Yearly hospitalization rates for pneumococcal, staphylococcal, Mycoplasma pneumoniae and influenza-related CAP were calculated over the study period.
Categorical variables were analysed using the X 2 or the X 2 for trend test (Cochran-Armitage test for trend). The statistical analyses were also performed using the SPSS software package (SPSS 11.5; Chicago, IL). P < 0.05 was considered statistically significant.
The study was approved by the Ethics Committee of the Anna Meyer Children's University Hospital.
RESULTS
During the study period, 5,450 children with i.so: 
-. ...... (Fig. 1) .
Yearly rate variations according to age, by aetiology Pneumococcal pneumonia
Total annual hospitalization rate for pneumococcal pneumonia was 28.04 (95% CI:26.42-31.23) per 100,000 children aged 0-5 years; 10.06 (95% CI:8.48-11.64) per 100,000 children aged 6-12 years; and 0.98 (95% CI:0.60-1.37) per 100,000 children aged 13-18 years (Fig.2 ). Yearly hospitalization rates by age group are reported in Table II (Table II) (Fig. 2) .
Mycoplasma pneumoniae
Hospitalization rates for Mycoplasma pneumoniarelated CAP were higher among children aged <5 years and 6-12 years than in children aged [13] [14] [15] [16] [17] [18] years. Annual hospitalization rates were 24.16 (95% CI: 21.96-26.37) per 100,000 children aged < 5 years, 20.12 (95% CI:17.89-22.36) and 2.32 (95% CI:1.73-2.91) per 100,000 children aged 6-12 and> 13 years, respectively (p<O.OOO 1) ( Fig. 3) .
Influenza related CAP
Globally, 74.82% (214/286) of all influenzarelated CAP that required hospitalization occurred in children aged under 5 years of age. Total hospitalization rates were 11.19 per 100,000 (95% IC:9-69-12.69) for children aged 0-5 years, 2.96 (95% IC:2.11-3.82) in children aged 6-12 years and 1.02 per 100,000 children aged [13] [14] [15] [16] [17] [18] year (95% CI:0.63-1.41) ( Fig. 5) . Rates significantly increased from 2008 to 2009 in all age groups (p<O.OOO 1). In particular, among children aged < 5 years influenza related rates requiring hospitalization increased 5.6-fold from 5.80 per 100,000 (95% CI:2.38-9.24) in 2008 to 32.51 (95% CI:24.48-40.54) in 2009 (p<O.OOOl) (Fig. 4) .
Complicated CAP
Overall hospitalization rate for complicated pneumonia was 9.00 (95% CI:8.25-9.76) per 100,000 living children. Complicated CAP cases globally ranged from 0.85% of all hospitalized cases in 2000 (21/2450) to 3.15% (80/2459) in 2009 (X2for trend=33.790; p<O.OOOl).
Annual hospitalization rates for complicated cases were 13.34 (95% CI:11.70-14.98) per 100,000 children aged under 5 years, 13.61(95% CI:11.77-15.459) per 100,000 children aged 6-12 years and 2.94 (95%CI:2.28-3.61)for children aged 13-18 years. Rates of complicated CAP cases and pneumococcal complicated CAP increased over the study period (X 2 for trend=15.085; p<O.OOOl and X 2 for trend=13.61; p<O.OOOI, respectively). Complicated pneumococcal CAP for all age groups are shown in Fig. 5 .
DISCUSSION
Hereby, we report changes in hospitalization rates for CAP and complicated CAP in a partially PCV7 vaccinated pediatric population over a 11year period. Overall hospitalization rates for CAP did not change significantly over time, however rates of complicated CAP, pneumococcal CAP and complicated pneumococcal CAP increased over time, particularly among children aged < 5 years.
Globally, annual CAP hospitalization rates ranged from 148.32 to 245.91 per 100,000 children under 5 years of age over the study period. Evidence obtained from literature indicates that the hospitalization rate for CAP in children varies across countries (3, 5, 16, 17, 23) . To date, little is known about epidemiological data on CAP hospitalization rates in Italian children. The few data available mostly concern pneumococcal infections (8-12). To our knowledge the present is the first Italian study that analyses hospitalization rates for all causes of CAP in children, including pneumococcal CAP over a long study period.
Some authors have previously reported hospitalization rates similarto our findings (5, (19) (20) (21) . In particular, rates were 101.9 per 100,000 children aged < 14 years, 261 per 100,000 children aged < 5 years and 397.7 per 100,000 children aged 1-5 years in Scotland, Germany and USA, respectively (3, 5, 21) . Higher CAP hospitalization rates have been reported among US children ranging from 1,267 per 100,000 in pre-PCV7 period to 852 per 100,000 during PCV7 period (2001-2007) for children aged < 2 years and from 402 to 404 per 100,000 children aged 2-4 years in pre-PCV7 and during PCV7 period respectively (18, 27) . The wide variability of rates might be influenced by the ages of the study children, geographical variables, different data collection and analysis methods and different admissions policies among studies (3, 16, (19) (20) (21) (22) 24) . Furthermore, PCV7 vaccine coverage varies among studies on the basis of specific immunization program. The successful PCV7 introduction into the childhood immunization program resulted in vaccine-type IPD reduction, including pneumococcal CAP, among United States, British, Canadian and Australian children (2, 15, (25) (26) (27) .
Despite the increasing number of PCV7 doses distributed from 2007 to 2009 in Tuscany, pneumococcal CAP hospitalization rates did not significantly decrease in the same years among children aged < 5 years. However, we noticed a decreasing trend from 2006 to 2008, then we reported a new increasing trend for pneumococcal CAP from year 2008 to 2009. This finding is difficult to explain. It could be influenced by several factors including the accuracy of aetiological diagnosis by employing PCR-based assay methods complementary to standard cultural methods in our study, the pneumococcal serotype replacement subsequent to the introduction of PCV7 (29, 30) or the increase in resistant serotypes as recently reported in the United States (30) .
Unfortunately, data on pneumococcal serotypes are not available in our study. However, a recent prospective cohort study, including data derived from only one city of our geographical area (Florence), found a total of 7 non-vaccine serotypes among the 22 children with IPD, suggesting approximately 31% of serotype replacements in this area of our region (11). However, modifications in IPD incidence and in pneumococcal serotype distribution may be due, at least in part, to other reasons, including a secular trend, as an example.
To our knowledge, available Italian data on IPD rates, particularly pneumococcal pneumonia and complicated pneumococcal CAP, are poor and inconsistent (8, 11, 12, 3 I) . We found an average pneumococcal CAP rate of 28.04 per 100,000 children < 5 years. A prospective surveillance on IPD by cultural methods was performed in two Italian regions in 2001 reporting a lower hospitalization rate (11 per 100,000) for children aged < 2 years. (36). Two studies confirm these findings in another Italian region (8, 9) . Finally similar results were found by Azzari et al. when data were obtained exclusively by using cultural methods (11). However, as suggested from the authors, these figures are significantly higher when molecular methods became available: hospitalization IPD rates reach 35.1 per 100,000 children aged <5 years (12) . These results are in agreement with our findings. The PCR-based assay molecular diagnostic test is performed complementary to standard cultural methods, in our Florentine Anna Meyer's Children University Hospital, a third hospital level where patients from all Tuscany were accepted, and specimens are usually sent to our laboratory from all hospitals of the region. This fact might have led to higher pneumococcal CAP rates compared with those reported in other European and Italian studies (9, 11, 31) .
Considering complicated CAP, we observed that hospitalization rates varied inversely with age, as expected (3). Annual hospitalization rate for complicated CAP was 13.34 per 100,000 children aged < 5 years. Notably, complicated CAP and complicated pneumococcal CAP rates increased over the study period. Our findings are consistent with other studies reporting increased rates of local associated CAP complications, particularly empyema, in recent years (3, 4, 16, 32) . Reported rates ranged from 3.8 to 5.4 per 100,000 children in pre PCV7 period (3, 32) and from 5.5 to 10.3 per 100,000 children aged 2-4 years during peV7 period (3, 32) . Particularly among United States children empyema hospitalization rates increased 70%, despite the dramatic decrease of pneumococcal pneumonia hospitalizations with widespread use of PCV7 (32) . The authors suggest that PCV7 could not be highly effective against serotypes mostly responsible for empyema, such as serotype 1 (32) . This fact suggests the real necessity to expand efficacy ofpneumococcal conjugate vaccines including serotypes commonly responsible for empyema. In Tuscany, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced for children under 2 years of age in 2010. Thus, epidemiological data could be further changed in future. Additionally, further studies in European countries that analyse microbiology of paediatric empyema cases would be necessary in order to monitor for serotype replacement.
Increase in hospitalization rate for CAP related to influenza A (H1N1) virus infection was noticed in 2009 in all age groups. This finding should be interpreted with caution. It might reflect parental and medical anxiety due to influenza A(H 1N1) virus pandemia in that year, which may have led to an increased number of hospitalizations due to prudential behaviour. On the other hand, we could not exclude that hospitalization rate for CAP related to influenza virus might be underestimated before 2009, since a PCR-based surveillance programme was organized at a national level in the 2009. The number of hospitalizations for complicated CAP related to influenza virus did not change significantly over the study period, suggesting that influenza A(H1N1) virus infection was not associated with relevant complications. Influenza A(H 1N1) virus infectionrelated alarmism could have create a considerable increase of costs for the Italian health care system with several children improperly hospitalized.
Our study may have some limitations. Firstly, some Tuscan children may have been admitted to an extraregional hospital. However. it is unlikely that this possible bias changed over the study period. Moreover, some children with less severe pneumonia might not be hospitalized. On the other hand, it is reasonable to assume that all children with complicated CAP were admitted to a hospital ward. CAP cases are identified by using discharge diagnosis code ICD-9. Although some diagnoses may have been misattributed or inadvertently excluded, these rare case should be equally distributed over years, thus not-affecting our results. ICD-9 as a source of epidemiological information is a simple, feasible, largely employable method to monitor the occurrence of some diseases (33) . The accuracy of ICD-9 codes for diagnosis of several diseases has been investigated in several studies in different countries suggesting that it can be considered a useful tool for epidemiological studies (33, 34) . Recently, other studies used ICD-9 or ICD-l 0 code diagnosis discharge to collect data on CAP cases, pneumococcal CAP and complicated CAP cases in children in several countries, including Italy (3, 8, 15, 16, 18, 24, 32) .
In conclusion, complicated CAP and pneumococcal CAP requmng hospitalization occurred at a substantial rate among the Tuscan pediatric population. Widespread PCV7 and then PCV13 could change CAP epidemiology and might influence hospitalization rate of pneumococcal and complicated CAP in the future. Thus, on-going epidemiological studies would be necessary to estimate precisely CAP hospitalization rates in Italian and European children. In particular, standard cultural methods should be complementarily employed to new molecular methods in order to improve etiological diagnosis of CAP cases and to monitor pneumococcal serotype replacement.
